Data Base Project for Acquisition of Cancer Patient Data in Practices and Ambulant Therapy
- Conditions
- Carcinoma
- Registration Number
- NCT02303353
- Lead Sponsor
- SPGO Research Mannheim GmbH
- Brief Summary
The purpose of this registry is to evaluate the situation regarding ambulant therapy of cancer patients in different practices in Germany. It should provide insight into the implementation of schemes for cancer therapy predefined in the guidelines, the treatment of diverse adverse reactions and the counter measures taken. Thereby, potential differences in treatment and with that differences in quality amongst individual practices might be identified. The medium to long term aim is to contribute to positively influence the quality of medical care of cancer patients in Germany.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 2000
- 18 years and older
- Tumor disease (carcinoma of either breast, ovary, lung, colon, stomach, pancreas, rectum or plasmacytoma)
- Written informed consent
none
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Anti-cancer treatments (Course of the disease and type of applied anti-cancer therapies. Assessment of guidelines' implementation) From date of ICF until date of cure/death/ICF withdrawal, up to 60 months Course of the disease and type of applied anti-cancer therapies. Assessment of guidelines' implementation
- Secondary Outcome Measures
Name Time Method Adverse reactions and their treatment (Number and type of adverse reactions and applied counter measures / therapies) From date of ICF until date of cure/death/ICF withdrawal, up to 60 months Number and type of adverse reactions and applied counter measures / therapies
Trial Locations
- Locations (1)
Practice
🇩🇪Mannheim, Germany